Latest News about NASDAQ:CNTXRecent news which mentions NASDAQ:CNTX Tickers
CNTX
From InvestorPlace
Tickers
CNTX
From InvestorPlace
Context Therapeutics CEO Marty Lehr notes progress towards the clinic with CTIM-76 in 2Q update
August 10, 2023
Tickers
CNTX
Tags
NASDAQ:CNTX
From News Direct
Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update
June 13, 2023
Tags
NASDAQ:CNTX
From News Direct
Context Therapeutics CTIM-76 bispecific antibody preclinical data presented at AACR Annual Meeting
April 24, 2023
Tags
NASDAQ:CNTX
From News Direct
Tags
NASDAQ:CNTX
From News Direct
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
December 06, 2022
Tags
NASDAQ:CNTX
From News Direct
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Kelownadailycourier.ca
Phone number: (250) 763-4000
E-mail: csr@ok.bc.ca
Address: 550 Doyle Avenue
Kelowna, BC V1Y 7V1
© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.